These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25900628)

  • 1. Effect of deuteration on metabolism and clearance of Nerispirdine (HP184) and AVE5638.
    Schofield J; Derdau V; Atzrodt J; Zane P; Guo Z; van Horn R; Czepczor V; Stoltz A; Pardon M
    Bioorg Med Chem; 2015 Jul; 23(13):3831-42. PubMed ID: 25900628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs.
    Sharma R; Strelevitz TJ; Gao H; Clark AJ; Schildknegt K; Obach RS; Ripp SL; Spracklin DK; Tremaine LM; Vaz AD
    Drug Metab Dispos; 2012 Mar; 40(3):625-34. PubMed ID: 22190693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and disposition of ABT-894, a novel α4β2 neuronal acetylcholine receptor agonist, in mice and monkeys.
    Liu H; Fu W; Wetter J; Xu H; Guan Z; Stuart P
    Xenobiotica; 2014 Jun; 44(6):531-40. PubMed ID: 24479584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of deuteration on the metabolism and clearance of some pharmacologically active compounds--synthesis and in vitro metabolism of deuterated derivatives of dronedadrone.
    Schofield J; Brasseur D; de Bruin B; Vassal T; Klieber S; Arabeyre C; Bourrié M; Sadoun F; Fabre G
    J Labelled Comp Radiopharm; 2013; 56(9-10):504-12. PubMed ID: 24285529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of N-methyl deuteration on metabolism and pharmacokinetics of enzalutamide.
    Jiang J; Pang X; Li L; Dai X; Diao X; Chen X; Zhong D; Wang Y; Chen Y
    Drug Des Devel Ther; 2016; 10():2181-91. PubMed ID: 27462143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological uses and perspectives of heavy water and deuterated compounds.
    Kushner DJ; Baker A; Dunstall TG
    Can J Physiol Pharmacol; 1999 Feb; 77(2):79-88. PubMed ID: 10535697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deuterium isotope effects in drug pharmacokinetics II: Substrate-dependence of the reaction mechanism influences outcome for cytochrome P450 cleared drugs.
    Sun H; Piotrowski DW; Orr STM; Warmus JS; Wolford AC; Coffey SB; Futatsugi K; Zhang Y; Vaz ADN
    PLoS One; 2018; 13(11):e0206279. PubMed ID: 30427871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588.
    Manley PW; Blasco F; Mestan J; Aichholz R
    Bioorg Med Chem; 2013 Jun; 21(11):3231-9. PubMed ID: 23611771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro-in vivo correlation for intrinsic clearance for CP-409,092 and sumatriptan: a case study to predict the in vivo clearance for compounds metabolized by monoamine oxidase.
    Kamel A; Colizza K; Gunduz M; Harriman S; Obach RS
    Xenobiotica; 2012 Apr; 42(4):355-62. PubMed ID: 22106962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacokinetic profile of highly deuterated brecanavir analogs.
    Velthuisen EJ; Baughman TM; Johns BA; Temelkoff DP; Weatherhead JG
    Eur J Med Chem; 2013 May; 63():202-12. PubMed ID: 23474906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.
    Naritomi Y; Terashita S; Kimura S; Suzuki A; Kagayama A; Sugiyama Y
    Drug Metab Dispos; 2001 Oct; 29(10):1316-24. PubMed ID: 11560875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
    Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
    Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimization.
    Li C; Chauret N; Trimble LA; Nicoll-Griffith DA; Silva JM; MacDonald D; Perrier H; Yergey JA; Parton T; Alexander RP; Warrellow GJ
    Drug Metab Dispos; 2001 Mar; 29(3):232-41. PubMed ID: 11181489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the mechanism of the carcinogenic activation of N-nitrosodiethanolamine with deuterium isotope effects: in vivo induction of DNA single-strand breaks and related in vitro assays.
    Loeppky RN; Fuchs A; Janzowski C; Humberd C; Goelzer P; Schneider H; Eisenbrand G
    Chem Res Toxicol; 1998 Dec; 11(12):1556-66. PubMed ID: 9860501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A metabolic screening study of trichostatin A (TSA) and TSA-like histone deacetylase inhibitors in rat and human primary hepatocyte cultures.
    Elaut G; Laus G; Alexandre E; Richert L; Bachellier P; Tourwé D; Rogiers V; Vanhaecke T
    J Pharmacol Exp Ther; 2007 Apr; 321(1):400-8. PubMed ID: 17218485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B.
    Pretorius A; Ogunrombi MO; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2008 Oct; 16(19):8813-7. PubMed ID: 18799315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of deuterated Tivozanib for improving pharmacokinetic properties.
    Guo S; Pang X; Peng L; Zhan M; Fan L; Gong Y; Kang F; Chen Y
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2425-8. PubMed ID: 25908516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver.
    Sanoh S; Horiguchi A; Sugihara K; Kotake Y; Tayama Y; Ohshita H; Tateno C; Horie T; Kitamura S; Ohta S
    Drug Metab Dispos; 2012 Feb; 40(2):322-8. PubMed ID: 22048522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.